Correlation Between Immix Biopharma and VTv Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and VTv Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and VTv Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and vTv Therapeutics, you can compare the effects of market volatilities on Immix Biopharma and VTv Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of VTv Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and VTv Therapeutics.

Diversification Opportunities for Immix Biopharma and VTv Therapeutics

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Immix and VTv is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and vTv Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on vTv Therapeutics and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with VTv Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of vTv Therapeutics has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and VTv Therapeutics go up and down completely randomly.

Pair Corralation between Immix Biopharma and VTv Therapeutics

Given the investment horizon of 90 days Immix Biopharma is expected to under-perform the VTv Therapeutics. In addition to that, Immix Biopharma is 1.11 times more volatile than vTv Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. vTv Therapeutics is currently generating about 0.13 per unit of volatility. If you would invest  1,357  in vTv Therapeutics on November 2, 2024 and sell it today you would earn a total of  109.00  from holding vTv Therapeutics or generate 8.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Immix Biopharma  vs.  vTv Therapeutics

 Performance 
       Timeline  
Immix Biopharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Immix Biopharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Immix Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.
vTv Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, VTv Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Immix Biopharma and VTv Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immix Biopharma and VTv Therapeutics

The main advantage of trading using opposite Immix Biopharma and VTv Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, VTv Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VTv Therapeutics will offset losses from the drop in VTv Therapeutics' long position.
The idea behind Immix Biopharma and vTv Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules